169 related articles for article (PubMed ID: 21983871)
1. The efficacy of miRNA122, a novel therapeutic target, for predicting the progression of hepatocellular carcinoma (HCC).
Wang L; Zhang Z; Wang FS
Cell Mol Immunol; 2012 Mar; 9(2):103-4. PubMed ID: 21983871
[No Abstract] [Full Text] [Related]
2. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma.
Pogribny IP; Rusyn I
Cancer Lett; 2014 Jan; 342(2):223-30. PubMed ID: 22306342
[TBL] [Abstract][Full Text] [Related]
3. microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity.
Zhang J; Yang Y; Yang T; Liu Y; Li A; Fu S; Wu M; Pan Z; Zhou W
Br J Cancer; 2010 Oct; 103(8):1215-20. PubMed ID: 20842113
[TBL] [Abstract][Full Text] [Related]
4. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.
D'Anzeo M; Faloppi L; Scartozzi M; Giampieri R; Bianconi M; Del Prete M; Silvestris N; Cascinu S
Molecules; 2014 May; 19(5):6393-406. PubMed ID: 24853455
[TBL] [Abstract][Full Text] [Related]
5. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.
Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH
Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in the Occurrence and Development of Primary Hepatocellular Carcinoma.
Xu J; Li J; Zheng TH; Bai L; Liu ZJ
Adv Clin Exp Med; 2016; 25(5):971-975. PubMed ID: 28028963
[TBL] [Abstract][Full Text] [Related]
7. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
Qiu L; Xu H; Ji M; Shang D; Lu Z; Wu Y; Tu Z; Liu H
Life Sci; 2019 Aug; 231():116660. PubMed ID: 31319086
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs involved with hepatocellular carcinoma (Review).
Mao B; Wang G
Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882
[TBL] [Abstract][Full Text] [Related]
9. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma.
Gailhouste L; Ochiya T
Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinoma.
Yoon JS; Kim G; Lee YR; Park SY; Tak WY; Kweon YO; Park JG; Lee HW; Han YS; Ha HT; Chun JM; Jang SY; Hur K
Biomark Med; 2018 Oct; 12(10):1105-1114. PubMed ID: 30191729
[TBL] [Abstract][Full Text] [Related]
11. Encouraging microRNA-based Therapeutic Strategies for Hepatocellular Carcinoma.
Yao M; Wang L; Qiu L; Qian Q; Yao D
Anticancer Agents Med Chem; 2015; 15(4):453-60. PubMed ID: 25511513
[TBL] [Abstract][Full Text] [Related]
12. High miR-139-3p expression predicts a better prognosis for hepatocellular carcinoma: a pooled analysis.
Zhu Y; Zhou C; He Q
J Int Med Res; 2019 Jan; 47(1):383-390. PubMed ID: 30394818
[TBL] [Abstract][Full Text] [Related]
13. The Role of Autophagy in Hepatocellular Carcinoma.
Lee YJ; Jang BK
Int J Mol Sci; 2015 Nov; 16(11):26629-43. PubMed ID: 26561802
[TBL] [Abstract][Full Text] [Related]
14. Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy.
Han LL; Lv Y; Guo H; Ruan ZP; Nan KJ
World J Gastroenterol; 2014 Aug; 20(30):10249-61. PubMed ID: 25132742
[TBL] [Abstract][Full Text] [Related]
15. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
Zhang C; Xia R; Zhang B; Wang H
BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of DNA methylation in hepatocellular carcinoma.
Sceusi EL; Loose DS; Wray CJ
HPB (Oxford); 2011 Jun; 13(6):369-76. PubMed ID: 21609368
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs as biomarkers for hepatocellular carcinoma diagnosis and prognosis.
He S; Zhang DC; Wei C
Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):426-34. PubMed ID: 25746139
[TBL] [Abstract][Full Text] [Related]
18. Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials.
Scaggiante B; Kazemi M; Pozzato G; Dapas B; Farra R; Grassi M; Zanconati F; Grassi G
World J Gastroenterol; 2014 Feb; 20(5):1268-88. PubMed ID: 24574801
[TBL] [Abstract][Full Text] [Related]
19. New kids on the block: diagnostic and prognostic microRNAs in hepatocellular carcinoma.
Ji J; Wang XW
Cancer Biol Ther; 2009 Sep; 8(18):1686-93. PubMed ID: 19901517
[TBL] [Abstract][Full Text] [Related]
20. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
Jin Y; Wang J; Han J; Luo D; Sun Z
Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
